Asthma

When Asthma leaves you out of breath,

A Clinical Research Study might just be an option for you.

Do you suffer from severe asthma attacks despite using an inhaler or taking controller medications?
Doctors and Researchers are testing out an investigational medication that might be able to help people suffering from persistent asthma symptoms.

You may qualify for the study if you:

Are 18 years or older
Have been diagnosed with the condition for at least 12 months
Are receiving treatment for your asthma symptoms (Advair, Symbicort, Breo, or AirDuo)

This study is being done to see if a new study medication may be able to help manage your symptoms better than other asthma medications that are currently available and approved.
*If you are eligible to participate in our Asthma clinical trials, you will receive the study treatment and care from healthcare professionals, free of cost to you and your health insurance.
*Your participation in the research study is completely voluntary and you are free to leave at any time.

*Who is this information for?

A Family Member

A Friend

My Patient

Please provide YOUR contact information only.

First Name

Last Name

Phone

Confirm Phone

Best time to call?

Morning

Middle of the day

Evening

State

How did you hear about us?*

Comments

User Agreement*

By Signing up, I agree to be contacted via calls and SMS.

About the Study

Approximately 206 volunteers will participate in the Asthma clinical trials at about 20 sites in the US, China, Ukraine, and the European Union. We are conducting a phase 2 research study to learn about the safety and efficacy of the study drug on human volunteers diagnosed with moderate to severe asthma, with Type 2 inflammation. You may be eligible for the research study if you are between the ages of 18 and 75 and have been diagnosed with allergic asthma by a physician, for at least 12 months.

Throughout the study trial, data on adverse events, clinical laboratory results, ECG findings, and vital signs will be collected to assess the drug’s tolerability and to ensure volunteer safety. This study will be divided into three phases:

Screening/run-in periods of 28 days to assess patient eligibility
Treatment period (24 weeks)
Post-treatment/follow-up period (8 weeks) to monitor patient status after study drug treatment has ended.

*The study drug and study-related care is free of charge for volunteers who are eligible for the study. If you qualify, you will receive a call from someone on our research staff. You may be asked to share your personal information regarding your complete medical history, overall health and any asthma medication you take.

*All volunteers who may be eligible for the research study will receive the study drug and study-related care, free of cost. And you may be compensated for your time and travel. No insurance is required to participate

Get Started: What to Expect?

In the study, participants who qualify will receive injections either containing the study drug or the placebo. The placebo is an injection that does not contain the study drug. This is a double-blinded, placebo-controlled research study. It means that neither you nor the study doctor will know if you’ve received the placebo or the study drug. We are conducting this research study to understand and compare the response observed in volunteers treated with the study drug to those receiving the placebo.

To see if you further qualify, you will be invited onto the study site for further medical tests and assessments. All volunteers are invited to ask as many questions as they’d like, before signing the Informed Consent Form. Your participation in the research study is completely voluntary.

Volunteers eligible for the research trial will receive study-related care from experienced healthcare professionals including doctors and nurses. Once the tests are complete, you will receive either the study medication or the placebo on Day 1. If you qualify for the research study, you will be monetarily compensated for your time and travel.

Get Started - See If You Qualify

Condition :

Asthma, Type 2 Inflammation

Length of Study Treatment

36 weeks

Number of Study Visits

About Asthma

This is a long-term condition that inflames the lungs, making breathing difficult. It can affect people of all ages and genders.

Understanding the Condition

Asthma symptoms arise when the lining of your airways stretches and the muscles surrounding them constrict. The excess mucus gradually fills up the airways, restricting the amount of air that may pass through them.

Symptoms of the Condition

Many of us are familiar with the most prevalent symptoms of this lung condition. This includes coughing, a whistling sound while breathing (wheezing), breathlessness, and a tight chest that feels like a band tightening around. However, sometimes all these symptoms can trigger a stronger episode, which worsens the condition temporarily and can be life-threatening.

Causes of Allergic Asthma

This condition develops when the breathing tubes that deliver air to the lungs become irritated. As a result, the tubes become extremely sensitive and restrictive. It may happen at any time or in response to anything that may be irritating.

Have you considered the typical factors that aggravate your allergic asthma condition? These include allergies (to house dust mites, animal fur, or pollen), smoke, pollution, cold air, exercise, and infections like colds or flu. Monitoring, avoiding triggers, and utilizing asthma medication may be able to help manage your condition. If current treatments are no longer working, consider joining our clinical trials that may be able to provide you with other options.

Frequently Asked Questions

Is there a cure for asthma?

Although there is no cure for this condition, asthma medication can help manage your symptoms so that you could live a normal life. The main treatment as of now are only inhalers, which are devices that allow you to breathe in the medicine.

What is the Asthma Study?

Research aids in our understanding of the disease’s causes, progression, and treatment options. For those who have been diagnosed with this condition, research can help to improve their quality of life. Revival Research Institute is conducting phase 2 Asthma clinical trials that may be able to help you and countless others. If you’d like to learn more about the study, please contact us.

According to the CDC, what is asthma?

According to the CDC, Asthma is a lung condition that affects people of all ages. It causes wheezing, dyspnea (shortness of breath), chest tightness, and coughing at night or early in the morning. Allergic asthma can be managed by taking medications and avoiding factors that can set off an episode. You should also eliminate your exposure to any irritants in the environment that may aggravate your condition.

Can asthma patients get the COVID vaccine?

Yes, people with underlying medical issues like asthma can get the COVID-19 vaccine if they haven’t had an allergic reaction to the vaccine or any of its ingredients in the past. Everyone who has been offered or has access to it should make use of it as soon as possible.

Will I get treatment if I join the study?

This is a double-blind, placebo-controlled research study. You might either receive the study treatment or the placebo. Neither you, nor your study doctor will know which treatment you’ve received unless it is absolutely necessary that your study doctor must know.

The study treatment might be able to help you with your allergic asthma symptoms or it might not. The placebo drug is simply sugar pills that do not contain the active ingredients. You will receive full study-related care from healthcare experts including doctors and nurses. All tests conducted during the course of the study and study-related care provided to you will be free of cost to you and your private health insurance.

Asthma Clinical Trials